What is the normal reference range for free testosterone (ng/dL) in a 55-year-old postmenopausal female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal Free Testosterone Range for 55-Year-Old Postmenopausal Women

For a 55-year-old postmenopausal woman, the normal free testosterone range is approximately 0.0025-0.0253 nmol/L (0.07-0.73 ng/dL), though significant inter-individual variability exists and age-specific reference ranges should be used when available 1.

Key Reference Values

The most robust data comes from a large cross-sectional study of 985 women aged 20-80 years using liquid chromatography-tandem mass spectrometry (LC-MS/MS), which established:

  • Free testosterone reference range (ages 20-80): 0.0025-0.0253 nmol/L
  • Converting to ng/dL: multiply nmol/L by 28.8, yielding approximately 0.07-0.73 ng/dL 1

This study used quantile regression to account for the strong age-dependency of testosterone in women and represents the gold standard methodology endorsed by the Endocrine Society 1.

Critical Context for Interpretation

Age-Related Decline

Total and free testosterone decline progressively with reproductive aging 2. However, the Endocrine Society guidelines emphasize that circulating testosterone levels do not reliably distinguish women in their late reproductive years from naturally postmenopausal women in the first decade after menopause 2. The between-woman variability is substantial, with considerable overlap between pre- and postmenopausal ranges 2.

Measurement Methodology Matters

The Endocrine Society strongly emphasizes that:

  • Direct immunoassays for free testosterone are seriously flawed and cannot be recommended 2
  • The most reliable methods are equilibrium dialysis or ultrafiltration 2
  • Calculated free testosterone (using total testosterone, SHBG, and albumin) is widely used and often comparable to measured values 2
  • LC-MS/MS is the preferred method for total testosterone measurement 2, 1

Common Pitfalls to Avoid

Laboratory selection is critical. Many commercial laboratories provide inaccurate normal ranges for testosterone, particularly in the low female range 3. Studies show the same testosterone value may be designated as normal to abnormally high depending on the laboratory's reference range 3.

Factors affecting interpretation in your 55-year-old patient:

  • Bilateral oophorectomy: Reduces free testosterone by 16% 4
  • Oral estrogen use: Reduces free testosterone by 47% 4
  • Obesity: Increases free testosterone by 20% (obese) or 14% (overweight) 4
  • Corticosteroid use: Reduces free testosterone by 43% 4

Practical Clinical Approach

When evaluating testosterone in a 55-year-old postmenopausal woman:

  1. Ensure proper testing: Request LC-MS/MS measurement of total testosterone with calculated free testosterone (not direct immunoassay)
  2. Verify laboratory quality: Confirm the lab uses appropriate reference ranges for postmenopausal women
  3. Consider clinical context: Account for medications (especially oral estrogen, corticosteroids), BMI, and surgical history
  4. Recognize variability: The reference range is wide, and individual variation is substantial 2, 1

The Endocrine Society guidelines note that despite improved assay methodology, not all mass spectrometry methods yield identical results, making calibration against agreed-upon standards essential 2.

References

Guideline

androgen therapy in women: a reappraisal: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2014

Guideline

american association of clinical endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2001

Research

Determinants of serum total and free testosterone levels in women over the age of 65 years.

The Journal of clinical endocrinology and metabolism, 2007

Related Questions

In a female patient with a free testosterone level of 0.4 pg/mL, what is the clinical significance and recommended next steps?
What is the optimal total and free testosterone level for a postmenopausal woman?
Is my free testosterone level borderline low, and what steps should be taken to evaluate and manage it?
Is a free testosterone level of 12.2 µg/dL (reference range 5.5–11.0 µg/dL) elevated, and what steps should be taken to evaluate and manage it?
In a 45-year-old female with estradiol 147 pg/mL, total testosterone 6 ng/dL, and progesterone 0.8 ng/mL, are these hormone levels normal and what treatment, if any, is recommended?
A postpartum day 5 patient presents with hypertension, headache, and a generalized petechial rash—what is the likely diagnosis and appropriate management?
What steps should I take for abdominal pain while taking Gufis (elobixibat)?
How should a patient with a post‑viral exanthematous rash and high‑grade fever be evaluated and managed?
What is the difference between coronary ectasia and coronary aneurysm?
Have you heard of the orthopaedic provider mentioned in my report who practices in [LOCATION]?
In a type 1 diabetic receiving parenteral nutrition (100 g dextrose with 19 U insulin) and continuous tube feeding (≈246 g carbohydrate per 24 h) who remains hyperglycemic despite NPH 20 U at 11 am and 20 U at 11 pm and now has infection with leukocytosis and fever, what NPH dose should be administered at 11 am and at 11 pm, and what insulin‑sensitivity factor should be used?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.